Results

1–10 of 45 results for RVO

Ixoberogene Soroparvovec (Ixo-vec) IVT Gene Therapy for Neovascular AMD: First Time 26-Week Interim Analysis Results from the Phase 2 LUNA Study
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2024
Impact of COVID-19 and Delay on Macular Edema After Retinal Vein Occlusion (MEfRVO) Comparing Ozurdex vs Anti-VEGF Therapy
John J. Huang, MD
Annual Meeting Talks
2022
Effects of Time Since Diagnosis to Intravitreal Aflibercept Injection and Baseline BCVA on Outcomes in CRVO: Post Hoc Analysis of the COPERNICUS and GALILEO Trials
Dilsher S. Dhoot, MD
Annual Meeting Talks
2022
The Bullet Ridden Retina
SHISHIR VERGHESE
Retina Image Bank: Images of the Week
2024
Ischemic Central Retinal Vein Occlusion Results in Greater Quadrant Asymmetry in OCTA Metrics
Quan V. Hoang, MD, PhD
On Demand Cases, Courses, and Papers
2021
Combined central retinal vein occlusion and branch retinal arteriolar occlusion
Retina Image Bank: Images of the Week
2022
OLD ISCHEMIC CRVO
Nivesh Gupta
Retina Image Bank: Images of the Week
2022
Analysis of Efficacy of Thrombophilia Workup in Retinal Vein Occlusion Patients
Katrina A Mears, MD, MSc FACS
Annual Meeting Talks
2021
Phase 2 Study of Two Formulations of AR-1105 in Macular Edema (ME) Secondary to Retinal Vein Occlusion (RVO)
Michael A. Singer, MD
Annual Meeting Talks
2021
Predictors of As-Needed Ranibizumab Injection Frequency in Patients With Macular Edema Following Retinal Vein Occlusion
Glenn C. Yiu, MD, PhD
Annual Meeting Talks
2021